Clinical Trials
12 trialsNCT00513526 2023-11-14
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
AIDS Malignancy Consortium
Phase 2 Completed
NCT04333914 2022-09-30
IMMUNONCOVID
Centre Leon Berard
Phase 2 Completed
NCT01321879 2019-12-27
Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02282215 2018-09-27
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Cellerant Therapeutics
Phase 2 Completed
NCT00335478 2017-05-09
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
OHSU Knight Cancer Institute
Phase 2 Completed
NCT00533078 2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2 Completed
NCT00589563 2014-09-10
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
City of Hope Medical Center
Phase 2 Completed
NCT00059878 2013-06-19
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
National Cancer Institute (NCI)
Phase 2 Completed
NCT00110045 2012-09-24
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00794261 2010-07-08
PALM
Centre Leon Berard
Phase 2 Completed
NCT00002673 2010-06-17
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT00430534 2007-02-02
Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).
Henogen
Phase 2 Completed